Sign In
Buy ASLN
$0.600
+0 (+0%)
At Close: Oct 17, 2024
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Thursday, 26'th Mar 2020
ASLAN Pharmaceuticals Ltd. (ASLN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
09:18am, Wednesday, 18'th Mar 2020
SINGAPORE, March 18, 2020 -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative.
ASLAN Pharmaceuticals to Present at 9th Annual SVB Leerink Global Healthcare Conference
07:05am, Monday, 24'th Feb 2020
ASLAN Pharmaceuticals Limited (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company, today announced its presentation at the 9th Annual SVB Leerink Globa
ASLAN Pharmaceuticals Ltd. (ASLN) Dips More Than Broader Markets: What You Should Know
10:50pm, Thursday, 20'th Feb 2020
ASLAN Pharmaceuticals Ltd. (ASLN) closed the most recent trading day at $2.10, moving -1.87% from the previous trading session.
ASLAN Pharmaceuticals Ltd. (ASLN) Stock Sinks As Market Gains: What You Should Know
10:45pm, Monday, 10'th Feb 2020
ASLAN Pharmaceuticals Ltd. (ASLN) closed at $2.11 in the latest trading session, marking a -0.94% move from the prior day.
Regeneron & Sanofi's sBLA for Dupixent Accepted by the FDA
03:39pm, Tuesday, 28'th Jan 2020
The FDA accepts Regeneron (REGN) and Sanofi's sBLA for Dupixent for Priority Review.
Has ASLAN Pharmaceuticals (ASLN) Outpaced Other Medical Stocks This Year?
04:30pm, Monday, 27'th Jan 2020
Is (ASLN) Outperforming Other Medical Stocks This Year?
Alexion to Start Pivotal Study on Ultomiris for ALS in Q1
09:34pm, Wednesday, 15'th Jan 2020
Alexion (ALXN) plans to initiate a phase III study on Ultomiris (ravulizumab) to treat amyotrophic lateral sclerosis.
Momenta (MNTA) Provides Pipeline Updates, Stock Rallies
01:22pm, Wednesday, 15'th Jan 2020
Shares of Momenta (MNTA) rise 23.7% on pipeline updates.
Ultragenyx Provides Preliminary Crysvita 2019 Revenues
01:53pm, Tuesday, 14'th Jan 2020
Ultragenyx (RARE) provides preliminary 2019 revenue numbers and 2020 outlook for Crysvita, along with other pipeline updates.
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Strong Buy: Here's Why
05:00pm, Monday, 13'th Jan 2020
ASLAN Pharmaceuticals Ltd. (ASLN) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near te
Is ASLAN Pharmaceuticals (ASLN) Outperforming Other Medical Stocks This Year?
05:04pm, Monday, 06'th Jan 2020
Is (ASLN) Outperforming Other Medical Stocks This Year?
Will ASLAN Continue to Surge Higher?
11:57am, Wednesday, 18'th Dec 2019
As of late, it has definitely been a great time to be an investor in ASLAN Pharmaceuticals.
SINGAPORE, Dec. 06, 2019 -- ASLAN Pharmaceuticals Limited (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced the.
The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial
12:59pm, Tuesday, 03'rd Dec 2019
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 2.) Aquestive Therapeutics Inc (NASDAQ: AQST )
